Adeno-associated virus (AAV) delivery of anti-FAM19A5 antibodies
US12215338B2 · kind B2 · utility
0Cited by
24References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 8, 2019 |
| Grant date | Feb 4, 2025 |
| Priority date | — |
| Expiry date | Sep 20, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2800/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides adeno-associated vims (AAV) vectors and uses thereof. In certain embodiments, the AAV vectors comprise a nucleic acid that encodes an antagonist against a family with sequence similarity 19, member A5 (FAM19A5) protein, e.g., anti-FAM19A5 antibody, e.g., anti-FAM19A5 scFv.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.